Ryan Chang, MD, PhD

Title(s)Clinical Fellow, Medicine
SchoolSchool of Medicine
AddressSan Bruno CA 94066
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. γδ T cells as critical anti-tumor immune effectors. Nat Cancer. 2024 Aug; 5(8):1145-1157. Arias-Badia M, Chang R, Fong L. PMID: 39060435.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    2. Vaccinating against cancer: getting to prime time. J Immunother Cancer. 2023 06; 11(6). Chang R, Gulley JL, Fong L. PMID: 37286302; PMCID: PMC10254974.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    3. Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor Immunity. Mol Pharm. 2021 03 01; 18(3):1014-1025. Levy ES, Chang R, Zamecnik CR, Dhariwala MO, Fong L, Desai TA. PMID: 33541072; PMCID: PMC10316682.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    4. DNA scaffolds enable efficient and tunable functionalization of biomaterials for immune cell modulation. Nat Nanotechnol. 2021 02; 16(2):214-223. Huang X, Williams JZ, Chang R, Li Z, Burnett CE, Hernandez-Lopez R, Setiady I, Gai E, Patterson DM, Yu W, Roybal KT, Lim WA, Desai TA. PMID: 33318641; PMCID: PMC7878327.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    5. DNA-scaffolded biomaterials enable modular and tunable presentation of proteins to control immune cell therapies. The Journal of Immunology. 2020 May 1; 204(1_Supplement):86.19-86.19. Huang HX, Williams WJ, Chang CR, Li LZ, Gai GE, Patterson PD, Wei WY, Lim LW, Desai DT. .
      View in: Publisher Site   Mentions:
    6. Optimization of a Polycaprolactone (PCL) Scaffold for Islet and Cellular Transplantation. Transplantation Journal. 2018 Jul 1; 102(&NA;):s304. Wisel WS, Faleo FG, Conkling CN, Chang CR, Stock SP, Desai DT, Tang TQ. .
      View in: Publisher Site   Mentions:
    7. Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy. ACS Nano. 2017 08 22; 11(8):7747-7757. Chang R, Faleo G, Russ HA, Parent AV, Elledge SK, Bernards DA, Allen JL, Villanueva K, Hebrok M, Tang Q, Desai TA. PMID: 28763191; PMCID: PMC5667644.
      View in: PubMed   Mentions: 33     Fields:    Translation:Animals
    8. Polycaprolactone Thin-Film Micro- and Nanoporous Cell-Encapsulation Devices. ACS Nano. 2015 Jun 23; 9(6):5675-82. Nyitray CE, Chang R, Faleo G, Lance KD, Bernards DA, Tang Q, Desai TA. PMID: 25950860; PMCID: PMC4628825.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    9. Imaging assessment of a portable hemodialysis device: detection of possible failure modes and monitoring of functional performance. Med Instrum (Luton). 2014 Mar 27; 2(2). Olorunsola OG, Kim SH, Chang R, Kuo YC, Hetts SW, Heller A, Kant R, Saeed M, Fissell WH, Roy S, Wilson MW. PMID: 25045526; PMCID: PMC4101171.
      View in: PubMed   Mentions: 1  
    10. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proc Natl Acad Sci U S A. 2012 Dec 04; 109(49):E3367-76. Luo W, Chang R, Zhong J, Pandey A, Semenza GL. PMID: 23129632; PMCID: PMC3523832.
      View in: PubMed   Mentions: 138     Fields:    Translation:HumansAnimalsCells
    11. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 2011 May 27; 145(5):732-44. Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R, Cole RN, Pandey A, Semenza GL. PMID: 21620138; PMCID: PMC3130564.
      View in: PubMed   Mentions: 733     Fields:    Translation:HumansAnimalsCells
    12. Impaired angiogenesis and mobilization of circulating angiogenic cells in HIF-1alpha heterozygous-null mice after burn wounding. Wound Repair Regen. 2010 Mar-Apr; 18(2):193-201. Zhang X, Liu L, Wei X, Tan YS, Tong L, Chang R, Ghanamah MS, Reinblatt M, Marti GP, Harmon JW, Semenza GL. PMID: 20163569; PMCID: PMC4206187.
      View in: PubMed   Mentions: 38     Fields:    Translation:AnimalsCells
    13. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. J Biol Chem. 2010 Feb 05; 285(6):3651-3663. Luo W, Zhong J, Chang R, Hu H, Pandey A, Semenza GL. PMID: 19940151; PMCID: PMC2823506.
      View in: PubMed   Mentions: 124     Fields:    Translation:HumansCells
    Ryan's Networks
    Concepts (88)
    Derived automatically from this person's publications.
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _